Publication:
CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial.

Loading...
Thumbnail Image

Date

2016-01-07

Authors

Corella, Dolores
Asensio, Eva M
Coltell, Oscar
Sorlí, José V
Estruch, Ramón
Martínez-González, Miguel Ángel
Salas-Salvadó, Jordi
Castañer, Olga
Arós, Fernando
Lapetra, José

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Circadian rhythms regulate key biological processes influencing metabolic pathways. Disregulation is associated with type 2 diabetes (T2D) and cardiovascular diseases (CVD). Circadian rhythms are generated by a transcriptional autoregulatory feedback loop involving core clock genes. CLOCK (circadian locomotor output cycles protein kaput), one of those core genes, is known to regulate glucose metabolism in rodent models. Cross-sectional studies in humans have reported associations between this locus and obesity, plasma glucose, hypertension and T2D prevalence, supporting its role in cardiovascular risk. However, no longitudinal study has investigated the association between CLOCK gene variation and T2D or CVD incidence. Moreover, although in a previous work we detected a gene-diet interaction between the CLOCK-rs4580704 (C > G) single nucleotide polymorphism (SNP) and monounsaturated (MUFA) intake on insulin resistance, no interventional study has analyzed gene-diet interactions on T2D or CVD outcomes. We analyzed the association between the CLOCK-rs4580704 SNP and incidence of T2D and CVD longitudinally in 7098 PREDIMED trial (ISRCTN35739639) participants after a median 4.8-year follow-up. We also examined modulation by Mediterranean diet (MedDiet) intervention (high in MUFA) on these associations. We observed a significant association between the CLOCK-rs4580704 SNP and T2D incidence in n = 3671 non-T2D PREDIMED participants, with variant allele (G) carriers showing decreased incidence (dominant model) compared with CC homozygotes (HR: 0.69; 95 % CI 0.54-0.87; P = 0.002). This protection was more significant in the MedDiet intervention group (HR: 0.58; 95 % CI 0.43-0.78; P In agreement with our previous results showing a protective effect of the G-allele against hyperglycemia, we extended our findings by reporting a novel association with lower T2D incidence and also suggesting a dietary modulation. Moreover, we report for the first time an association between a CLOCK polymorphism and stroke in T2D subjects, suggesting that core clock genes may significantly contribute to increased CVD risk in T2D.

Description

MeSH Terms

Aged
Aged, 80 and over
CLOCK Proteins
Cardiovascular Diseases
Chi-Square Distribution
Circadian Rhythm
Diabetes Mellitus, Type 2
Diet, Mediterranean
Gene Frequency
Gene-Environment Interaction
Genetic Predisposition to Disease
Heterozygote
Homozygote
Humans
Incidence
Kaplan-Meier Estimate
Longitudinal Studies
Male
Middle Aged
Multivariate Analysis
Phenotype
Polymorphism, Single Nucleotide
Proportional Hazards Models
Protective Factors
Risk Assessment
Risk Factors
Spain
Time Factors
Treatment Outcome

DeCS Terms

CIE Terms

Keywords

Citation